Oxygenta Pharmaceutical Ltd Company Summary

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990. The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited. Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22.

The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The Company has plant located at Medak in Andhra Pradesh.

The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. Apart from these, it is doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from Q-Acid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production.

This contract manufacturing helped the Company to meet major operational expenses. Since the Company started commercial production in July, 2015 after fire accident tragedy, it is in process of stabilizing the manufacturing and marketing.